ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
고양이 백신 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 12억 6,000만 달러에서 2026년에는 13억 8,000만 달러로, CAGR 9.2%로 확대될 전망입니다. 지난 몇 년간의 성장 요인으로는 고양이 전염병 발생률 증가, 첨단 백신 공급 제한, 반려동물 사육 가구 증가, 동물병원 확대, 정부 주도의 백신 접종 정책 등을 꼽을 수 있습니다.
고양이 백신 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 19억 3,000만 달러에 달하고, CAGR은 8.9%가 될 전망입니다. 예측 기간 동안의 성장 요인으로는 백신 개발의 기술적 진보, 재조합 백신 및 DNA 백신에 대한 수요 증가, 반려동물 예방 의료에 대한 인식 증가, 온라인 수의학 서비스 확대, 질병 모니터링에 AI 및 데이터 분석의 통합 등이 있습니다. 예측 기간 동안 주요 동향으로는 핵심 백신 접종 프로그램의 도입 확대, 재조합 백신 및 DNA 백신의 성장, 동물 건강 관리 서비스 확대, 반려동물 건강 및 질병 예방에 대한 인식 증가, 동물 건강 관리에서 원격의료와 원격 모니터링의 통합 등이 있습니다.
인수공통전염병의 증가는 고양이 백신 시장의 성장을 촉진할 것으로 예상됩니다. 인수공통전염병은 세균, 바이러스, 곰팡이, 기생충 등 다양한 병원체를 통해 동물에서 사람에게 감염되는 질병입니다. 이러한 질병은 직접 접촉, 매개체, 오염된 환경을 통해 전파됩니다. 대표적인 인수공통전염병으로는 라임병, 광견병, 톡소플라스마증, 살모넬라증, 브루셀라증 등이 있습니다. 인수공통전염병의 증가에 기여하는 요인으로는 기후변화, 항생제 내성, 야생동물 거래 등을 들 수 있습니다. 고양이 백신은 고양이에서 사람으로의 감염 위험을 줄여 이러한 질병 관리에 기여합니다. 예를 들어, 톡소플라스마증, 고양이 긁힘병과 같은 질병으로부터 보호합니다. 고양이 백신 접종은 인수공통전염병이 인간의 건강에 미치는 영향을 완화하고, 공중 보건을 지원하며, 반려동물과 보호자 모두에게 더 건강한 환경을 조성합니다. 영국 정부의 2024년 2월 보고서에 따르면, 영국에서 2023년 4분기에 335건의 라임병 확진자가 확인되어 2022년 같은 기간의 273건보다 증가했다고 합니다. 이는 인수공통전염병의 확산에 따라 고양이 백신에 대한 수요가 증가하고 있음을 보여줍니다.
고양이 백신 시장의 주요 기업들은 NOBIVAC NXT 백신과 같은 제품으로 혁신을 거듭하고 있습니다. 이 백신은 첨단 리보핵산(RNA) 입자 기술을 사용하여 면역 반응을 촉진하고 백신 효과를 높입니다. 이 기술에서는 나노입자에 봉입된 RNA 분자가 세포에 유전정보(유전지시)를 전달하여 특정 단백질을 생산하게 하고, 표적 면역반응을 유발합니다. 예를 들어, 2024년 6월 MSD 애니멀헬스사는 'NOBIVAC NXT Rabies' 제품군을 발표했으며, 여기에는 'NOBIVAC NXT Feline-3 Rabies'와 'NOBIVAC NXT Canine-3 Rabies'가 포함되어 있습니다. 이 백신은 보조제나 방부제를 사용하지 않고 개와 고양이에 대한 광견병에 대한 강력한 방어력을 제공하며, 효과는 유지하면서 안전성을 향상시켰습니다. 체액성 면역과 세포성 면역을 모두 자극하여 광견병 바이러스에 대한 종합적인 방어를 실현합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장에서 세계의 총 잠재 시장 규모(TAM)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자 환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSM
영문 목차
영문목차
A cat vaccine is a biological agent designed to safeguard cats from infectious diseases by activating their immune system to identify and combat specific pathogens. These vaccines use weakened or inactivated versions of viruses or bacteria responsible for diseases, which prompts the cat's immune system to generate antibodies without causing illness.
Ther main categories of cat vaccines are modified or attenuated live vaccines, inactivated vaccines, and others. Modified or attenuated live vaccines involve weakening the pathogen to prevent it from causing illness in cats. These vaccines address various diseases such as feline leukemia, feline panleukopenia, feline respiratory infections, and feline rabies. The available vaccine technologies include attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines. They can be administered through different methods, including injections, intranasal, and oral routes. These vaccines are available through various channels, including veterinary clinics, pet stores, and online retailers.
Tariffs have influenced the cat vaccine market by affecting the cost and availability of imported vaccine components, raw materials, and advanced biotechnological equipment. These tariffs have increased production costs, particularly impacting segments like recombinant and DNA vaccines and regions heavily reliant on imports such as North America and Europe. While tariffs pose challenges in terms of cost pressures, they also encourage local manufacturing and innovation, potentially driving the development of cost-efficient vaccines and strengthening regional supply chains.
The cat vaccine market research report is one of a series of new reports from The Business Research Company that provides cat vaccine market statistics, including cat vaccine industry global market size, regional shares, competitors with a cat vaccine market share, detailed cat vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the cat vaccine industry. This cat vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cat vaccine market size has grown strongly in recent years. It will grow from $1.26 billion in 2025 to $1.38 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to rising incidence of feline infectious diseases, limited availability of advanced vaccines, growth of pet ownership, expansion of veterinary clinics, government vaccination initiatives.
The cat vaccine market size is expected to see strong growth in the next few years. It will grow to $1.93 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to technological advancements in vaccine development, increasing demand for recombinant and dna vaccines, rising awareness of preventive healthcare in pets, expansion of online veterinary services, integration of ai and data analytics in disease monitoring. Major trends in the forecast period include increased adoption of core vaccination programs, growth of recombinant and dna vaccines, expansion of veterinary healthcare services, rising awareness of pet health and disease prevention, integration of telemedicine and remote monitoring in veterinary care.
The rise in zoonotic diseases is expected to drive the growth of the cat vaccine market. Zoonotic diseases are infections that can transfer from animals to humans through various pathogens such as bacteria, viruses, fungi, or parasites. These diseases can be transmitted via direct contact, vectors, or contaminated environments. Common zoonotic diseases include Lyme disease, rabies, toxoplasmosis, salmonellosis, and brucellosis. Factors contributing to the increase in zoonotic diseases include climate change, antibiotic resistance, and wildlife trade. Cat vaccines help manage these diseases by reducing the risk of transmission from cats to humans. For instance, they protect against diseases such as toxoplasmosis and cat scratch fever. By vaccinating cats, the impact of zoonotic diseases on human health is mitigated, supporting public health and creating a healthier environment for both pets and their owners. According to a February 2024 report from the Government of the United Kingdom, England saw 335 confirmed cases of Lyme disease in the fourth quarter of 2023, up from 273 cases in the same period in 2022. This increase underscores the growing demand for cat vaccines driven by rising zoonotic diseases.
Key players in the cat vaccine market are innovating with products such as NOBIVAC NXT vaccines, which use advanced Ribonucleic acid (RNA)-particle technology to boost immune responses and enhance vaccine effectiveness. This technology involves RNA molecules encased in nanoparticles that deliver genetic instructions to cells, prompting them to produce specific proteins that trigger a targeted immune response. For example, in June 2024, MSD Animal Health Inc. launched the NOBIVAC NXT Rabies portfolio, including NOBIVAC NXT Feline-3 Rabies and NOBIVAC NXT Canine-3 Rabies. These vaccines offer robust protection against rabies for cats and dogs without adjuvants or preservatives, improving safety while maintaining efficacy. They stimulate both humoral and cell-mediated immune responses for comprehensive protection against the rabies virus.
In September 2024, Boehringer Ingelheim Group, based in Germany, acquired Saiba Animal Health AG, a Switzerland-based company specializing in cat vaccines. This acquisition aligns with Boehringer Ingelheim's strategy to expand its portfolio and leverage Saiba's expertise in the field.
Major companies operating in the cat vaccine market are Merck & Co. Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., MSD Animal Health, Elanco Animal Health Incorporated, Ceva Sante Animale, Virbac, HIPRA Corporation, Bioveta AS, Biogenesis Bago SA, Torigen Pharmaceuticals Inc., Vetoquinol SA, Phibro Animal Health Corporation, IDT Biologika GmbH, Vaxxinova BV, Colorado Serum Company, Huvepharma NV, Bimeda Biologicals, CAVAC, Kyoto Biken Laboratories, Avimex Animal Health, Ringpu Biology, Wuhan Keqian Biology, Pulike Biological Engineering, Chengdu Kanghua Biological Products, Yebio, FATRO
North America was the largest region in the cat vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cat vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cat vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cat vaccine market consists of sales of the bordetella vaccine, rabies vaccine, and feline immunodeficiency virus (FIV) vaccine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cat Vaccine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cat vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cat vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cat vaccine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Vaccine Type: Modified Or Attenuated Live; Inactivated; Other Vaccine Types
2) By Disease Type: Feline Leukemia; Feline Panleukopenia; Feline Respiratory Diseases; Feline Rabies; Other Disease Types
3) By Technology: Attenuated Live Vaccines; Conjugate Vaccines; Inactivated Vaccines; Subunit Vaccines; Toxoid Vaccines; Deoxyribonucleic Acid (DNA) Vaccines; Recombinant Vaccines
4) By Route Of Administration: Injectables; Intranasal; Oral
5) By Distribution Channel: Veterinary Clinics; Pet Stores; Online Retailers
Subsegments:
1) By Modified Or Attenuated Live: Feline Viral Rhinotracheitis (FVR) Vaccine; Feline Calicivirus (FCV) Vaccine; Feline Panleukopenia (FPV) Vaccine
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.1.5 Biotechnology, Genomics & Precision Medicine
4.2. Major Trends
4.2.1 Increased Adoption Of Core Vaccination Programs
4.2.2 Growth Of Recombinant And Dna Vaccines
4.2.3 Expansion Of Veterinary Healthcare Services
4.2.4 Rising Awareness Of Pet Health And Disease Prevention
4.2.5 Integration Of Telemedicine And Remote Monitoring In Veterinary Care
5. Cat Vaccine Market Analysis Of End Use Industries
5.1 Veterinary Clinics
5.2 Pet Hospitals
5.3 Pet Owners
5.4 Animal Shelters
5.5 Pet Stores
6. Cat Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Cat Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Cat Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Cat Vaccine Market Size, Comparisons And Growth Rate Analysis
7.3. Global Cat Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Cat Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Cat Vaccine Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Cat Vaccine Market Segmentation
9.1. Global Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Modified Or Attenuated Live, Inactivated, Other Vaccine Types
9.2. Global Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.4. Global Cat Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Injectables, Intranasal, Oral
9.5. Global Cat Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Veterinary Clinics, Pet Stores, Online Retailers
9.6. Global Cat Vaccine Market, Sub-Segmentation Of Modified Or Attenuated Live, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.8. Global Cat Vaccine Market, Sub-Segmentation Of Other Vaccine Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Recombinant Vaccines, DNA Vaccines, Subunit Vaccines, Combination Vaccines
10. Cat Vaccine Market Regional And Country Analysis
10.1. Global Cat Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Cat Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Cat Vaccine Market
11.1. Asia-Pacific Cat Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Cat Vaccine Market
12.1. China Cat Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Cat Vaccine Market
13.1. India Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Cat Vaccine Market
14.1. Japan Cat Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Cat Vaccine Market
15.1. Australia Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Cat Vaccine Market
16.1. Indonesia Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Cat Vaccine Market
17.1. South Korea Cat Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Cat Vaccine Market
18.1. Taiwan Cat Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Cat Vaccine Market
19.1. South East Asia Cat Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Cat Vaccine Market
20.1. Western Europe Cat Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Cat Vaccine Market
21.1. UK Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Cat Vaccine Market
22.1. Germany Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Cat Vaccine Market
23.1. France Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Cat Vaccine Market
24.1. Italy Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Cat Vaccine Market
25.1. Spain Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Cat Vaccine Market
26.1. Eastern Europe Cat Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Cat Vaccine Market
27.1. Russia Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Cat Vaccine Market
28.1. North America Cat Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Cat Vaccine Market
29.1. USA Cat Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Cat Vaccine Market
30.1. Canada Cat Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Cat Vaccine Market
31.1. South America Cat Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Cat Vaccine Market
32.1. Brazil Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Cat Vaccine Market
33.1. Middle East Cat Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Cat Vaccine Market
34.1. Africa Cat Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Cat Vaccine Market, Segmentation By Vaccine Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Cat Vaccine Market Regulatory and Investment Landscape
36. Cat Vaccine Market Competitive Landscape And Company Profiles
36.1. Cat Vaccine Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Cat Vaccine Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Cat Vaccine Market Company Profiles
36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. MSD Animal Health Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
37. Cat Vaccine Market Other Major And Innovative Companies
Ceva Sante Animale, Virbac, HIPRA Corporation, Bioveta AS, Biogenesis Bago SA, Torigen Pharmaceuticals Inc., Vetoquinol SA, Phibro Animal Health Corporation, IDT Biologika GmbH, Vaxxinova BV, Colorado Serum Company, Huvepharma NV, Bimeda Biologicals, CAVAC, Kyoto Biken Laboratories
38. Global Cat Vaccine Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Cat Vaccine Market
40. Cat Vaccine Market High Potential Countries, Segments and Strategies
40.1 Cat Vaccine Market In 2030 - Countries Offering Most New Opportunities
40.2 Cat Vaccine Market In 2030 - Segments Offering Most New Opportunities
40.3 Cat Vaccine Market In 2030 - Growth Strategies
